Table 3 Linear regression results highlighting univariate associations between sample size (categorized as <100, 100–500, 500–1000, >1000), journal impact factor (categorized as <3, 3–5, 5–10 and >10) and publication year with APPRAISE-AI overall scores
Variable | Mean difference in APPRAISE-AI overall score | 95% confidence interval | p value | R2 |
|---|---|---|---|---|
Univariate linear regression | ||||
Impact factor [Reference IF < 3] | 0.026 | 0.21 | ||
IF 3–4.9 | 5.8 | −1.5–13.1 | ||
IF 5–9.9 | 8.1 | −0.97–17.1 | ||
IF > 10 | 15.5 | 4.5–26.5 | ||
Sample size [Reference: <100 patients] | 0.002 | 0.31 | ||
100–499 patients | 8.4 | −1.0–17.7 | ||
500–1000 patients | 10.3 | 0.2–20.4 | ||
>1000 patients | 18.3 | 8.4–28.2 | ||
Publication year | 0.65 | 0.04–1.27 | 0.034 | 0.11 |
Multivariable linear regression | ||||
Impact factor [Reference IF < 3] | 0.041 | 0.65 | ||
IF 3–4.9 | 0.49 | −5.9–6.9 | ||
IF 5–9.9 | 5.9 | −2.6–12.3 | ||
IF > 10 | 10.4 | 0.8–20.0 | ||
Sample size [Reference: <100 patients] | <0.001 | |||
100–499 patients | 11.4 | 3.6–19.1 | ||
500–1000 patients | 8.8 | 0.09–17.6 | ||
>1000 patients | 18.7 | 10.9–26.6 | ||
Publication year (per 1-year increase) | 0.70 | 0.23–1.16 | 0.002 | |
Country of data collection [high-income country with reference to upper middle-income country] | 8.6 | 1.7–15.4 | 0.011 | |